Background Cardiogenic shock (CS) induced by severe aortic stenosis (AS) is a life-threatening condition with high mortality.

The outcomes of the SHOCK trial led to a ACC/AHA class 1A recommendation for an early invasive strategy in acute MI complicated by cardiogenic ... ACC/AHA/SCAI 2005 guideline update for ...

according to a study by the Cardiogenic Shock Working Group (CSWG) presented at ESC Congress 2024 in London and simultaneously published in JACC. Van-Khue Ton, MD, PhD, et al., used the CSWG-modified ...

CS indicates cardiogenic shock; CS‐TTS, cardiogenic shock complicating Takotsubo syndrome; RETAKO, Registry of Takotsubo syndrome; and SCAI, Society for Cardiovascular Angiography and Interventions.

To position istaroxime for Phase 3 readiness, WINT launched the small Phase 2 study in SCAI Stage C. SCAI Stage C cardiogenic shock is a more severely ill patient population than the participants ...

Additionally, the Society for Cardiovascular Angiography and Interventions (SCAI) has developed a staging system to classify the severity of cardiogenic shock. Recent research has validated this ...

we plan to accelerate enrollments in the istaroxime SCAI Stage C cardiogenic shock study as well as provide guidance on our ...